Purpurogallin in the prevention of hypercholesterolemic atherosclerosis

International Journal of Angiology

Volumn 6, Issue 3, 1997, Pages 157-166

  Prasad, Kailash ^a,b   Mantha, Subrahmanyam V ^a   Kalra, Jawahar ^a   Kapoor, Rakesh ^a   Kamalarajan, Baylon R C ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PURPUROGALLIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; FEMALE; HISTOLOGY; HYPERCHOLESTEROLEMIA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

EID: 0030976843     PISSN: 10611711     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01616174     Document Type: Article

References (46)

1. Claus EP (1965) Pharmacognosy, 3rd. ed. Lea and Febiger, Philadelphia, pp 231-233.
2. Critchlow A, Haslam E, Haworth RD, Tinker PB, Waldron NM (1967) The oxidation of some pyrogallol and purpurogallin derivatives. Tetrahedron 23:2829-2847.
3. Anderson WA (1980) Hydroxylic aromatic compounds as additives for rubber based, composite solid propellants. U.S. Patent 4181545 assigned to United Technologies Corporation.
4. Prasad K, Laxdal VA (1994) Evaluation of hydroxyl radical-scavenging property of purpurogallin using high pressure liquid chromatography. Mol Cell Biochem (in press).
5. Prasad K, Kapoor R, Lee P (1994) Purpurogallin. a scavenger of polymorphonuclear leukocyte-derived oxyradicals. Mol Cell Biochem (in press).
6. Prasad K, Kalra J (1989) Experimental atherosclerosis and oxygen free radicals. Angiology 40:835-843.
7. Prasad K, Kalra J (1993) Oxygen-free radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 125:958-973.
8. Prasad K, Kalra J, Lee P (1994) Oxygen-free radicals as a mechanism of hypercholesterolemic atherosclerosis: Effects of probucol. Int J Angiol (in press).
9. Mantha SV, Prasad M, Kalra J, Prasad K (1993) Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis 101:135-144.
10. Prasad K, Lee P, Mantha SV, Kalra J, Prasad M, Gupta JB (1992) Detection of ischemia-reperfusion cardiac injury by cardiac muscle chemiluminescence. Mol Cell Biochem 115:49-58.
11. Daugherty A, Zweifel BS, Shonfeld G (1989) Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br J Pharmacol 98:612-618.
12. Kritchevsky D, Kim HK, Tepper SA (1971) Influence of 4,4′-(isopropyldenedithio) bis (2,6-di-t-butylphenol) (DH-581) on experimental atherosclerosis in rabbits (35461). Proc Soc Exp Biol Med 136:1216-1221.
13. Tawara K, Ishihara M, Ogawa H, Tomikawa M (1986) Effect of probucol, pantethine and their combinations on serum lipoprotein metabolism and on the incidence of atheromatous lesions in the rabbit. Jpn J Pharmacol 41:211-222.
14. Wahlefeld AW (1974) Triglyceride determination after enzymatic hydrolysis. In: Methods in Enzymatic Analysis. Bergmeyer HU (ed). Verlag Chemie Weinheim/Academic Press Inc: New York, p 1831.
15. Deeg R, Ziegenhom J (1982) Kinetic enzymatic method for automated determination of serum total cholesterol (abstract). Clin Chem 28: 1574.
16. Lopes-Virella MF, Stone P. Ellis S, Colwell JA (1977) Cholesterol determination in high density lipoprotein separated by three different methods. Clin Chem 23:882-884.
17. Assmann G (1979) Lipiddiagnostik Leute. In: Lipoproteine und Herzingarkt, ed. Greten H et al. (eds) Witzstrock-Verlag: Baden-Baden, W. Germany, p 29.
18. Prasad K, Kalra J, Chaudhary AK, Debnath D (1990) Effect of polymorphonuclear leukocyte-derived oxygen-free radicals and hypochlorous acid on cardiac function and some biochemical parameters. Am Heart J 119:538-550.
19. Yagi K (1976) A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212-216.
20. Prasad K, Chaudhary AK, Kalra J (1991) Oxygen-free radicals producing activity and survival of activated polymorphonuclear leukocytes. Mol Cell Biochem 103:51-62.
21. Holman RS, McGill, HC Jr, Strong JP, Greer JC (1958) Technics for studying atherosclerotic lesions. Lab Invest 7:42-47.
22. Baily JM, Butler J (1985) Anti-inflammatory drugs in experimental atherosclerosis. Part 6. Combination therapy with steroids and non-steroid agents. Atherosclerosis 54:205-212.
23. Henriksson P, Bergström K, Edhag O (1985) Experimental atherosclerosis and possible generation of free radicals. Thrombosis Res 38:195-198.
24. Wojcicki J, Samochowiec L, Jaworska M, Hinek A (1985) A search for a model of experimental atherosclerosis: Comparative studies in rabbits, guinea pigs and rats. Pol J Pharmacol Pharm 37:11-21.
25. Sugano M, Nakashima Y, Tasaki H, Takasugi M, Kuroiwa A, Koide O (1988) Effects of diltiazem on suppression and regression of experimental atherosclerosis. Br J Exp Pathol 69:515-523.
26. Del Boccio G, Lapenna D, Forreca E, et al (1990) Aortic antioxidant defence mechanisms: Time-related changes in cholesterol-fed rabbits. Atherosclerosis 81:127-135.
27. Frank L, Messaro D (1980) Oxygen toxicity. Am J Med 69:117-126.
28. Oei HH, Stroo WE, Burton KP, Schaffer SW (1982) A possible role of xanthine oxidase in producing oxidative stress in the heart of chronically ethanol-treated rats. Res Commun Chem Pathol Pharmacol 38: 453-461.
29. Shull S, Heintz NH, Periasamy M, et al (1991) Differential regulation of antioxidant enzymes in response to antioxidant. J Biol Chem 266: 24398-24403.
30. Bray RC, Cockle SA, Martin-Fielden E, Roberts PB, Rotilio G, Calabrese L (1982) Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem J 139:43-48.
31. Kono Y, Fridovich I (1982) Superoxide radical inhibits catalase. J Biol Chem 257:5751-5754.
32. Kono Y, Fridovich I (1983) Inhibition and reactivation of Mn-catalase. J Biol Chem 258:13646-13648.
33. Blum J, Fridovich I (1985) Inactivation of glutathione peroxidase by superoxide dismulase radical. Arch Biochem Biophys 240:500-508.
34. Michelson AM, Maral J (1983) Carbonate anions: Effects on the oxidation of luminol oxidative hemolysis, γ-irradiation and the reaction of activated oxygen species with enzymes containing various active centers. Biochimie 65:95-104.
35. Pearson TA, Malmros H, Dillman J, Sternby N, Heptinstall RH (1987) Atherosclerosis in the hypercholesterolemic hare. Comparison of coronary artery lesions induced by dietary cholesterol in the hare and rabbit. Atherosclerosis 63:125-135.
36. Hollander W, Kramsch DM, Franzglau C, Paddock J, Colombo MA (1974) Suppression of atheromatous fibrous plaque formation by antiproliferative and anti-inflammatory drugs. Cir Res 34 (suppl I):131-141.
37. Kaul D, Kukreja RS (1987) Atherogenesis: Preventive action of trifluoperazine. Atherosclerosis 64:211-214.
38. Warren JS, Ward PA (1986) Oxidative injury to vascular endothelium. Am J Med Sci 292:97-103.
39. Egan RW, Paxton J, Kuehl FA Jr (1976) Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem 251:7329-7335.
40. Murota SI, Morita I, Suda N (1990) The control of vascular endothelial cell injury. Ann NY Acad Sci 598:182-187.
41. Sacks T, Moldow CF, Craddock PR, Bowers TK, Jacob HS (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J Clin Invest 61:1161-1167.
42. 2 in vivo. Am J Physiol 264:L566-L574.
43. Ingerman-Wojenski CM, Sedar AW, Nissenbaum M, Silver MJ, Klurfeld DM, Kritchevsky D (1983) Early morphological changes in endothelium of rabbits fed on atherogenic diet. Exp Mol Pathol 38:48-60.
44. Ross R, Harker L (1976) Hyperlipidemia and atherosclerosis: Chronic hyperlipidemia initiates and maintains lesions by endothelial cell desquamation and lipid accumulation. Science 193:1094-1100.
45. Ross R (1986) The pathogenesis of atherosclerosis - An update. N Engl J Med 314:488-500.
46. Ross R (1993) Atherosclerosis: A defense mechanism gone awry. Am J Pathol 143:987-1002.